Harrison SJ - Search Results

1

Panobinostat in patients with relapsed/refractory Hodgkin's lymphoma after autologous stem-cell transplantation: results of a phase II study.

Younes A, Sureda A, Ben-Yehuda D, Zinzani PL, Ong TC, Prince HM, Harrison SJ, Kirschbaum M, Johnston P, Gallagher J, Le Corre C, Shen A, Engert A. Younes A, et al. Among authors: harrison sj. J Clin Oncol. 2012 Jun 20;30(18):2197-203. doi: 10.1200/JCO.2011.38.1350. Epub 2012 Apr 30. J Clin Oncol. 2012. PMID: 22547596 Clinical Trial.

2

Immunotherapy of multiple myeloma: the start of a long and tortuous journey.

Harrison SJ, Cook G, Nibbs RJ, Prince HM. Harrison SJ, et al. Expert Rev Anticancer Ther. 2006 Dec;6(12):1769-85. doi: 10.1586/14737140.6.12.1769. Expert Rev Anticancer Ther. 2006. PMID: 17181491 Review.

3

The potential of histone deacetylase inhibitors for the treatment of multiple myeloma.

Prince HM, Bishton M, Harrison S. Prince HM, et al. Leuk Lymphoma. 2008 Mar;49(3):385-7. doi: 10.1080/10428190801950058. Leuk Lymphoma. 2008. PMID: 18297514

4

The development of novel immunotherapeutic approaches in multiple myeloma.

Peinert S, Prince HM, Harrison S. Peinert S, et al. Leuk Lymphoma. 2008 Apr;49(4):652-4. doi: 10.1080/10428190802007742. Leuk Lymphoma. 2008. PMID: 18398729 Review. No abstract available.

5

Predicting durable remissions following thalidomide therapy for relapsed myeloma.

Quach H, Mileshkin L, Seymour JF, Milner A, Ritchie D, Harrison S, Westerman D, Prince HM. Quach H, et al. Leuk Lymphoma. 2009 Feb;50(2):223-9. doi: 10.1080/10428190802663213. Leuk Lymphoma. 2009. PMID: 19194832 Clinical Trial.

6

Clinical studies of histone deacetylase inhibitors.

Prince HM, Bishton MJ, Harrison SJ. Prince HM, et al. Among authors: harrison sj. Clin Cancer Res. 2009 Jun 15;15(12):3958-69. doi: 10.1158/1078-0432.CCR-08-2785. Epub 2009 Jun 9. Clin Cancer Res. 2009. PMID: 19509172 Review.

7

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma.

Quach H, Ritchie D, Stewart AK, Neeson P, Harrison S, Smyth MJ, Prince HM. Quach H, et al. Leukemia. 2010 Jan;24(1):22-32. doi: 10.1038/leu.2009.236. Epub 2009 Nov 12. Leukemia. 2010. PMID: 19907437 Free PMC article. Review.

8

Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma.

Thompson PA, Prince HM, Seymour JF, Ritchie D, Stokes K, Burbury K, Wolf M, Peinert S, Joyce T, Harrison SJ. Thompson PA, et al. Among authors: harrison sj. Bone Marrow Transplant. 2011 May;46(5):764-5. doi: 10.1038/bmt.2010.180. Epub 2010 Aug 2. Bone Marrow Transplant. 2011. PMID: 20676149 No abstract available.

9

The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy.

Hsu AK, Quach H, Tai T, Prince HM, Harrison SJ, Trapani JA, Smyth MJ, Neeson P, Ritchie DS. Hsu AK, et al. Among authors: harrison sj. Blood. 2011 Feb 3;117(5):1605-13. doi: 10.1182/blood-2010-04-278432. Epub 2010 Oct 26. Blood. 2011. PMID: 20978269 Free article.

10

Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor-induced thrombocytopenia.

Bishton MJ, Harrison SJ, Martin BP, McLaughlin N, James C, Josefsson EC, Henley KJ, Kile BT, Prince HM, Johnstone RW. Bishton MJ, et al. Among authors: harrison sj. Blood. 2011 Mar 31;117(13):3658-68. doi: 10.1182/blood-2010-11-318055. Epub 2011 Feb 3. Blood. 2011. PMID: 21292776 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296 results

Search Page

Filters